Sheila C. Takieddine, PharmD

Drug Policy Development Specialist,
University of Cincinnati Medical Center

Poster(s):

• (423) Evaluation of Methylnaltrexone and Enteral Naloxone for Opioid-Induced Constipation
  Sunday, January 21, 2024

  12:15 PM – 1:15 PM MT